Dr. Thomas Chacko, MD

Dr. Chacko practices at Chacko Allergy in Alpharetta, Georgia.

Dr. Chacko's NPI, 1356443089, was assigned on September 2, 2006. Dr. Chacko graduated from Sidney Kimmel Medical College in 2002. Dr. Chacko holds Georgia license 59383.

Dr. Chacko's primary practice is Chacko Allergy, at 3905 Brookside Pkwy, Alpharetta, GA 30022 in Fulton County. The practice phone is (678) 668-4688.

Dr. Chacko's primary practice is Chacko Allergy in Alpharetta, Georgia. The medical group on file is Chacko Allergy, Asthma and Sinus Center. Dmand AI also links Dr. Chacko to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chacko practices. Vendor and product names are available with a free account.

Allergy is Dr. Chacko's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Chacko is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Chacko's licenses on file in 3 states: Georgia, Florida and New York.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies and hives among the conditions Dr. Chacko treats.

CMS data shows 8,856 Medicare services from Dr. Chacko across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $79,454 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Dr. Chacko in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chacko's median patient age at 20, with 53% women.

In 2024, Dr. Chacko wrote 774 Medicare Part D claims for 225 patients. 76% of them were for generic drugs. CMS names the drug for 655 of them, across 14 drugs with 11 or more claims each, at $322,434 in total drug cost. In 2023, CMS named 597 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Chacko for performance year 2024, reported individually. Dr. Chacko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Chacko, published from 2002 to 2003. The most frequent topics are Fluorodeoxyglucose F18 and Radiopharmaceuticals. Dr. Chacko has published most often in Eur J Nucl Med Mol Imaging. Dr. Chacko's most frequent co-authors are Abass Alavi, MD, Hongming Zhuang, MD and Dennis K. Ledford, MD.

CMS Open Payments shows 508 general payments to Dr. Chacko from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Novartis Pharmaceuticals Corporation paid the most, $30,678.

Dr. Chacko graduated from Sidney Kimmel Medical College in 2002. Dr. Chacko is a member of AAAAI.

Dr. Chacko is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.